• Wed, August 17, 2016
  • Thu, August 18, 2016
  • Fri, August 19, 2016
  • Mon, August 22, 2016

Matthew Harrison Maintained (BIIB) at Buy with Decreased Target to $368 on, Aug 17th, 2016

Matthew Harrison of Morgan Stanley, Maintained "Biogen Inc." (BIIB) at Buy with Decreased Target from $385 to $368 on, Aug 17th, 2016.

Matthew has made no other calls on BIIB in the last 4 months.



There is 1 other peer that has a rating on BIIB. Out of the 1 peers that are also analyzing BIIB, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew


  • Aaron Gal of "Bernstein" Initiated at Buy on, Wednesday, June 29th, 2016

Like: 👍